Research Articles
A Single-Tablet Revolution: Simplifying HIV Treatment for Kidney Failure Patients
Breakthrough research shows B/F/TAF single-tablet regimen offers safe, effective HIV treatment for patients with end-stage renal disease on hemodialysis.
Switching HIV Treatments: How Bictegravir Stacks Up Against Dolutegravir
Comparative analysis of Bictegravir and Dolutegravir-based HIV treatments, examining viral suppression, adherence, and long-term outcomes in clinical trials and real-world settings.